COMPANY PROFILE

Message

The “tissue culture technology” developed in the 19th century has greatly advanced to the “cell culture technology” in which cells are cultured in vitro in the 20th century. This cell culture technology has greatly contributed to research on cancer diseases and viral infections, and has become a new technology for the development of various vaccines.

In the 21st century, pluripotent cells such as ES and iPS cells that differentiate into various cell lineages were created, and the potential of “regenerative medicine” to treat incurable diseases was expanded by these cells. With the development of regenerative medicine, the cell culture media required for in vitro cell culture has become a very important basic material for safe regenerative cell therapy.

We will continue to develop high-performance cell culture media using know-how gained from research and development of cell culture media over many years, and contribute to the development of regenerative cell medicine and biopharmaceuticals.

CEO/President Takeshi Sato

Company Profile

Representative
Executive Chairman TOKUDA MASANORI
(Honorary Professor Tohoku University)
CEO SATO TAKESHI
Head Office
82-16,Imozawa Gongenmoriyama, Aoba-ku, Sendai
989-3212 Japan
TEL. +81-22-343-5116
URL: www.cellscience.co.jp
Capital
10 million JPY
Established
April 10,2015
Employees
9 (as of May 2019)
Bank
Mizuho Bank, Ltd
Morinomiyako Shinkin Bank

Access

PAGE TOP